ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Incomplete Penetrance in Autoinflammatory Diseases

Michael Cammarata, MD, RhMSUS  |  November 1, 2025

To explore this further, they isolated B cells from the cousins carrying the mutation, as well as healthy controls, then sorted B cells based on calcium flux, a functional outcome measure. They found that the B cells with negative calcium flux were only expressing the mutant allele, and the cousin with normal IgG levels expressed both alleles. This was the second example of monoallelic expression correlating with phenotypic output.

In Sum

Monoallelic expression occurs naturally in all humans and explains some instances of incomplete penetrance in inborn errors of immunity. Why this occurs remains an unanswered question; however, Dr. Bogunovic closed by framing MAE in the broader context of human evolution: genes deemed bad get kicked out, and those that are good are passed down over generations. MAE, he proposed, allows for a form of personal evolution, allowing genetic flexibility and tonality to the genome.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Bogunovic speculated that patients with rheumatic disease may have skewed biallelic expression during an active disease flare—a question that his laboratory continues to investigate. He also highlighted the invaluable contributions of his colleagues, including Conor Gruber, O’Jay Stewart and Haley Randolph, PhD, whose work was instrumental in advancing their research.


Michael Cammarata, MD, RhMSUS, is an assistant professor of medicine at the Johns Hopkins University School of Medicine in Baltimore.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ACR ConvergenceConditionsMeeting Reports Tagged with:ACR Convergence 2025geneticsinborn errors of immunitymonoallelic expressionResearch

Related Articles
    Stmool / shutterstock.com

    How to Avoid Cognitive Errors in Rheumatology

    March 14, 2022

    The 1999 Institute of Medicine report To Err Is Human gave a sobering depiction of the magnitude and consequences of medical error.1 The report concluded that approximately 98,000 people die in hospitals annually due to preventable medical errors. Of all the errors detailed in this report, diagnostic errors have since been determined to be the…

    T Cells in Systemic Lupus Erythematosus

    August 1, 2011

    Progress toward targeted therapy

    A&R Abstracts – T CELLS

    August 1, 2011

    For Further Reading

    Doest Rheumatoid Arthritis Take a Toll?

    November 15, 2013

    Exploring the Toll background

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences